You need to enable JavaScript to run this app.
Recon: FDA approves OTC switch for naloxone for opioid reversal; ICU Medical bids against GE Healthcare for Medtronic units valued at $8B
Recon
Joanne S. Eglovitch
Global
ReconJoanne S. Eglovitch
GlobalReconJoanne S. EglovitchGlobal